New Delhi: America’s top infectious disease specialist Dr Anthony Fauci on Thursday said his country is eager to involve Indian investigators in global clinical trials to evaluate the safety and efficacy of COVID therapeutics.
The National Institute of Allergy and Infectious Diseases has a long history of collaboration with its counterpart agencies in India, Dr Fauci said during a conversation organized by the US-India Strategic and Partnership Forum.
Under the long-standing Indo-US vaccine action programme, we will continue to work with India on research related to SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) vaccines. We also are eager to involve Indian investigators in sites in global clinical trials to evaluate the safety and efficacy of various COVID therapeutics, he said. The partnerships between the NIH and India’s Department of Biotechnology as well as what the Indian Council of Medical Research have helped produce important scientific and public health discoveries in the past.
Meanwhile, in the last 24 hours, India logged 1,32,364 COVID infections and 2,713 people succumbed to the pandemic, the country’s Health and Family Welfare Ministry said.
Free Press Kashmir is now on Telegram. Click here to Join.
FPK Android App for 2G. Click here to Download.
